RP Management, LLC
- SEC CIK
- 0001507673
- Latest filing
- Aug 6, 2025
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 10, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 4
- 0 vs. Q1 2022
- Portfolio value
- $249.4M
- +$7.37M (+3.0%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BHVNBiohaven Ltd. | COM | 1,111,111 | $161.9M | 64.9% | 00.0% | Unchanged | History |
| EPZMEpizyme, Inc. | COM | 31,841,394 | $46.8M | 18.8% | +8,0600.0% | Added | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 3,846,154 | $40.7M | 16.3% | 00.0% | Unchanged | History |
| VIRXViracta Therapeutics, Inc. | COM | 3,700 | $18.0K | <0.1% | 00.0% | Unchanged | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Epizyme Inc29428V904 | CALL | – | $3.79M |